INTRODUCTION
Streptococcus pneumoniae is one of the leading causes of septicaemia, meningitis and lower-respiratory-tract infections in humans. Despite rapid and aggressive antibiotic therapy, pneumococcal infection can lead to a variety of debilitating complications, including hearing loss. A better understanding of the cellular biochemistry of the pneumococci is essential for the development of novel anti-microbial therapeutics.
Thymidylate kinase (dTMP kinase or TMK; EC 2.7.4.9) catalyses the terminal phosphoryl group transfer from ATP to dTMP in the biosynthesis of the pyrimidine deoxyribonucleotide, dTTP. The cascade of enzymes that activate nucleosides to nucleoside triphosphates and deoxynucleoside triphosphates (NTPs and dNTPs respectively) is of interest in drug discovery, in that these molecules are vital precursors in the synthesis of DNA, RNA and other cellular macromolecules (peptidoglycan in bacteria). TMK is no exception, and has been extensively studied both as an anti-viral target and for its potential role in cancer therapy. Variability in the active site residues and catalytic properties of TMK enzymes from various sources (viral, eukaryotic and bacterial) has opened the possibility of designing specific and selective inhibitors. The essential nature of TMK for bacterial growth ( [1] ; C. Petit, unpublished work), and the fact that the protein is found in both Gram-negative and Gram-positive human bacterial pathogens, render this enzyme an attractive target for the development of novel, broad-spectrum antibacterial agents.
TMK enzymes are globular dimeric proteins with a similar fold to that found in other nucleoside monophosphate kinases [2] , with three loops crucial for enzyme activity : the phosphatebinding motif at the N-terminus (P-loop), the nucleoside-monophosphate-binding domain, and the region which covers part of the P-loop upon substrate binding (LID domain). Variability in Abbreviations used : TMK, thymidylate kinase ; AZT-MP, 3h-azido-3h-deoxythymidine 5h-monophosphate ; ADP[β-S], adenosine 5h-[β-thio]diphosphate ; TMK coli , TMK from an Escherichia coli source, etc. ; ITC, isothermal titration calorimetry ; ATP [S] , adenosine [γ-thio]triphosphate ; Ches, 2-(Ncyclohexylamino)ethanesulphonic acid. 1 To whom correspondence should be addressed (e-mail ChantalIPetit-1!gsk.com).
Furthermore, AZT-MP (3h-azido-3h-deoxythymidine 5h-monophosphate) was shown not to be a substrate for S. pneumoniae TMK. Steady-state kinetics and inhibition studies with adenosine 5h-[β-thio]diphosphate and dTDP in addition to isothermal titration calorimetry were performed. The data showed that binding follows an ordered pathway, in which ATP binds first with a K m of 235p46 µM and a K d of 116p3 µM, and dTMP binds secondly with a K m of 66p12 µM and a K d of 53p2 µM.
Key words : AZT-MP, dissociation constants, dTMP kinase, kinetic mechanisms, nucleotide specificity.
phosphorylation of the anti-viral pro-drug 3h-azido-3h-deoxythymidine 5h-monophosphate (AZT-MP) was first identified when comparing the activity of the bacterial and eukaryotic TMK enzymes [2] [3] [4] [5] . Kinetic measurements with the enzyme from an Escherichia coli source (TMK coli ) showed that the maximum rate of AZT-MP phosphorylation is reduced only by a factor of 2 in comparison with dTMP, whereas this reduction is 200-fold for TMK yeast and TMK human [3, 6, 7] . Crystal structures of TMK yeast complexed with dTMP [5] , AZT-MP [5] and P"-(5hadenosyl)-P&-(5h-thymidyl)pentaphosphate (TP & A) [8] , and structures of TMK coli complexed with TP & A and with P"-(5hadenosyl)-P&-[5h-(3h-azido-3h-deoxythymidine)] pentaphosphate (' AZT-P & A') [6] were solved. Analysis of these structures indicated that the reduction in the maximum rate of AZT-MP phosphorylation in eukaryotic TMKs is the result of a transition-state-stabilizing arginine residue located in the P-loop being shifted out of place by the movement of the adjacent invariant aspartate residue due to steric interactions with the amide group of AZT-MP. In contrast, this essential arginine residue is located in the LID region, not the P-loop, in TMK coli . Consequently, the P-loop does not shift when binding AZT-MP and phosphorylation can occur efficiently. These reports prompted Chenal-Francisque et al. [7] to investigate further bacterial TMK enzymes. Characterization of the Yersinia pestis enzyme (TMK pestis ) highlighted a striking difference in terms of its ability to phosphorylate AZT-MP compared with TMK coli . The V max obtained with AZT-MP as substrate was only 1 % that obtained with dTMP for TMK pestis , whereas only a 2-fold difference in V max was observed between AZT-MP and dTMP for TMK coli . Even though the two bacterial enzymes share higher sequence homology than they do with their eukaryotic counterparts, the Y. pestis enzyme behaves more similarly to the yeast and human enzymes than to the E. coli enzyme. This variation in V max was demonstrated further with Haemophilus influenzae and Salmonella typhi : the maximum rate of phosphorylation of AZT-MP in the former was more similar to that of TMK pestis , while the maximum rate in the latter was more similar to that of TMK coli [7] . When comparing the protein sequences of TMK pestis and TMK coli , three non-conserved residues within the active site were identified, which might account for the variability in the maximum phosphorylation rate for AZT-MP (Lys&&, Leu(# and Ser"!$ in TMK pestis replaced by Leu&&, Phe(% and Thr"!& in TMK coli ) [7] . Interestingly, the authors also reported that TMK from another Gram-positive human pathogen, Mycobacterium tuberculosis, does not use AZT-MP as a substrate. A preliminary X-ray-crystallographic analysis of TMK tuberculosis complexed with dTMP was reported recently, which should clarify further its substrate specificity [1] .
The kinetic mechanism of mouse TMK and those of the homologous enzymes guanylate kinase and adenylate kinase have been shown to be random Bi Bi in nature, i.e. in which the nucleotides bind independently of each other [9] [10] [11] . Recent studies on the mechanism of the human enzyme implied that it too would function with random binding of the substrates [2] . However, no data are available on the catalytic mechanism of their bacterial counterparts.
In an effort to investigate the kinetic mechanism of TMK from the human pathogen S. pneumoniae, the gene was cloned and expressed in E. coli and the protein was subsequently purified. The enzyme was characterized for its substrate specificity. Results obtained from initial-velocity experiments and by isothermal titration calorimetry (ITC) suggest that the mechanism is ordered, with ATP binding first and dTMP binding secondly. We show that the streptococcal enzyme does not utilize AZT-MP as a substrate, as is the case for other bacterial enzymes, and discuss this difference.
EXPERIMENTAL Materials
All chemicals were of analytical grade, and were used without further purification. The nucleotides dTMP, dTDP, adenosine 5h- 
Cloning, expression and purification
The S. pneumoniae tmk gene was PCR-amplified from genomic DNA using the following primers : 5h-GAGTTACAT ATGTCA-AAAGGATTTTTAGTCTCTC-3h and 5h-GTTGATGAATTC-TTATTTGGCCAAGCCC-3h. These primers were engineered to create an NdeI site at the N-terminus of the gene, and an EcoRI site at the C-terminus (sequences of the restriction enzyme sites are shown in bold, and the start and stop codons are underlined). The gene was isolated and cloned into pET28a(j) as an NdeI-EcoRI fragment to encode an N-terminally hexahistidinetagged protein with a thrombin cleavage site after the tag. The construct was expressed in E. coli strain BL21(DE3), and induced with 1 mM isopropyl β--thiogalactoside (' IPTG ') at 37 mC for 3 h in Luria-Bertani medium containing 50 µg : ml " kanamycin. The TMK protein was expressed at a level of approx. 25 % of the total protein (of which about 50 % was soluble), as judged by SDS\PAGE. The protein was then purified to 95 % homogeneity by Ni# + -chelate chromatography, using a HiTrap chelating column and the conditions recommended by the manufacturer (Amersham Biosciences, Piscataway, NJ, U.S.A.).
Enzyme assay
All the reactions were performed in 96-well plates (Labsystems, Helsinki, Finland) in an assay volume of 100 µl. The TMK activity was measured at 25 mC by coupling the formation of ADP with the reaction catalysed by pyruvate kinase (4 units) and lactate dehydrogenase (4 units) in the presence of 50 mM KCl, 1 mM phosphoenolpyruvate and 0.1 mM NADH. The reaction was initiated by the addition of 20 nM TMK, except when stated otherwise. The molar ratio of MgCl # : ATP was kept constant at 2. Oxidation of NADH was monitored by fluorescence (λ ex l 355 nm; λ em l 460 nm) using a BMG PolarStar plate reader (BMG Labtechnologies Inc., Durham, NC, U.S.A.). The activities are expressed as arbitrary units : s ". All data fitting was performed with non-linear least-squares regression, using the commercial software package Graphit 4.0 (Erithacus Software, Horley, Surrey, U.K.).
ITC
ITC experiments were performed using a VP-ITC titration microcalorimeter (Microcal Inc., Northampton, MA, U.S.A.). The reference cell was filled with water. The TMK protein was dialysed overnight in 50 mM Hepes buffer, pH 8.5, containing 5 mM MgCl # . Substrate solutions were prepared in the final dialysis buffer. Solutions of the TMK protein were filled in the sample cell (1.4 ml volume) and titrated with ATP[S] or dTMP solutions. ITC experiments were routinely performed at 25 mC. Raw data were collected and integrated using the Microcal Origin software supplied with the instrument. The data were fitted to a single-site binding model by a non-linear regression analysis to yield binding constants (K B ), enthalpies of binding (∆H) and the stochiometry of binding.
Other methods
The N-terminal amino acid sequence of the purified enzyme was deduced by automated Edman degradation with a HewlettPackard (Boise, ID, U.S.A.) model G1000A sequencer. The molecular mass of the enzyme was determined by matrix-assisted laser-desorption ionization-time-of-flight MS using a PerSeptive Biosystems Voyager RP Biospectrometer (Framingham, MA, U.S.A.). Protein concentration was determined by amino acid hydrolysis.
RESULTS
S. pneumoniae histidine-tagged TMK was overexpressed in E. coli and purified to homogeneity by Ni# + -chelate chromatography (results not shown). The effect of pH on enzyme activity was examined. The buffers used were Ches, Tris and Mes, all at a concentration of 50 mM. The ionic strength was held constant at 50 mM by adding various concentrations of NaCl (see http:\\ www.bi.umist.ac.uk\users\mjfrbn\Buffers\Makebuf.asp). TMK was found to have an optimum activity between pH 8 and pH 9 ( Figure 1 ). The effect of NaCl was examined further in 50 mM Tris\HCl, pH 8.5. No significant change was observed when the NaCl concentration was varied from 0-50 mM (results not shown), and therefore the remaining experiments were
Figure 1 Effect of pH on S. pneumoniae TMK activity
The assays were performed as described in the Experimental section using the following buffers : 50 mM Mes for pH measurements between pH 5.6 and 6.7, 50 mM Tris/HCl for pH 7.1-9, and 50 mM Ches for pH 9.2-9.9. Velocities are expressed in arbitrary units (AU) : s 1 . Each point represents the average of experiments performed in duplicate.
Table 1 Specificity of S. pneumoniae TMK for nucleotides
Experiments were performed at 25 mC and pH 8.5. Activities are expressed as percentages in comparison with a control using ATP and dTMP as substrates. The concentration of each nucleotide added to the reaction was 2 mM. In the case of AZT-MP, activity was tested with up to a 100-fold greater enzyme concentration as compared with the amount used when testing the other phosphate acceptors. performed in 50 mM Tris at pH 8.5, in the absence of NaCl. To determine substrate specificity, various NTPs or dNTPs were tested as phosphate donors in combination with NMPs or dNMPs as phosphate acceptors. Not only ATP, but also dATP (reaction velocity 80 % of that of ATP) and, to a lesser extent, CTP (reaction velocity 20 % of that of ATP) could act as phosphate donors (Table 1 ). Of the NMPs tested, only dTMP and, to a lesser extent, dUMP (reaction velocity 15 % of that of dTMP) could act as phosphate acceptors for S. pneumoniae TMK (Table 1) . Interestingly, no activity was detected when using AZT-MP as a phosphate acceptor, even when the amount of enzyme was increased 100-fold (2 µM) as compared with the amount used for the other nucleotides (20 nM; Table 1 ).
Initial velocity analysis
The kinetics of the forward reaction (formation of ADP and dTDP) was measured by coupling the reaction with those of pyruvate kinase and lactate dehydrogenase [12] . Enzyme assays were performed in a 5i5 array with various concentrations of ATP (100-800 µM) and dTMP (25-150 µM). Initial velocities were fitted to eqn (1) :
where A and B represent the concentration of ATP and dTMP respectively. The double-reciprocal plots of the kinetic data are linear, and they intersect, which is indicative of a ternary mechanism ( Figure 2) . A standard curve with NADH concentrations ranging from 0-100 µM was performed. The velocities obtained in arbitrary units of fluorescence:s " were then converted into units of µM NADH oxidized:s " to calculate k cat , and the second-rate constant k cat \K m . The kinetic parameters are summarized in Table 2 .
Product inhibition studies
Since the reaction product ADP is a substrate for the coupling enzyme pyruvate kinase used in the assay, product inhibition experiments were performed using the non-hydrolysable product analogue ADP[β-S]. The concentrations tested were 0, 50, 100 and 200 µM. The data fitted best to a competitive-inhibition model against ATP (eqn 2), and a non-competitive model against dTMP (eqn 3; Figures 3A and 3B) . Similarly, inhibition patterns with dTDP were obtained at various concentrations. Data were fitted to a non-competitive model against ATP (eqn 3) and a competitive-inhibition model against dTMP (eqn 2; Figures 4A  and 4B ). The inhibition constants are summarized in Table 3 .
ITC experiments
Since Mg# + is required for the phosphorylation reaction catalysed by S. pneumoniae TMK, and since it could influence the titrations. The titration with ATP[S] was characterized by a significant exothermic heat effect, with a ∆H of k10.1 kcal:mol " (1 cal 4.184 J). The binding constant K B was determined to be 8605p222 M " (meanspS.E.M., provided by the ITC software when fitting data), which corresponds to a K d of 116p3 µM. In contrast, titration with dTMP unveiled a very different kinetic behaviour : no heat effect typical of a binding reaction was
Figure 5 Representative isothermal titration calorimetry measurements
Titrations were performed at 25 mC in 50 mM Hepes, pH 8. 
DISCUSSION
TMK has an essential role in both the de no o and salvage pathways of dTTP synthesis, with dTTP serving as a precursor in the synthesis of DNA. The role of TMK renders it an attractive target for the development of anti-microbial agents. The differences between eukaryotic and prokaryotic TMK proteins within the active site, taken together with the lack of mechanistic data in the literature, prompted us to undertake the characterization of the kinetic mechanism of TMK from the human pathogen S. pneumoniae.
The mechanism of the forward reaction was explored using both steady-state kinetics and ITC. Double-reciprocal plots of the initial-velocity data disclosed intersecting lines. These results are characteristic of a sequential mechanism. Both substrates behaved as Michaelis-Menten substrates over the range of concentrations studied. The K m values of ATP and dTMP were 235p46 µM and 66p12 µM respectively; the k cat was calculated to be 8.9p0.9 s ". These values are in the same order of magnitude as that reported for the TMK enzymes of E. coli and Y. pestis [7] , embryonic chick liver [13] , and cells of human chronic myelocytic leukaemia [14] or HSV-1-and HSV-2-infected cells [15] . Using ADP[β-S] as an analogue of ADP and dTDP, it was not possible to distinguish with certainty between a random and an obligatory order of addition. From the inhibition studies, the mode of inhibition with ADP[β-S] was competitive against ATP and noncompetitive against dTMP, and with dTDP the inhibition was non-competitive against ATP and competitive against dTMP. However, we showed by ITC that only ATP[S] could bind to the free TMK, unlike dTMP or dTDP. Binding of dTMP was observed only when the complex TMK[ATP[S] was pre-formed. These results support an ordered Bi Bi mechanism, and would differ from those obtained for mouse TMK [9] or that suggested by the structural results obtained with the human enzyme [2] . No kinetic mechanism has been proposed as yet for the bacterial TMKs, and it is possible to envisage major differences between bacterial and non-bacterial enzymes.
The substrate specificity was evaluated. Of the NMPs tested, dTMP was the best phosphate acceptor. The results for the nucleoside triphosphates were very similar to those reported in E. coli and Y. pestis, with ATP and dATP being effective as phosphate donors, and CTP being moderately effective as a phosphate donor [7] . However, an unexpected difference between S. pneumoniae TMK and the enzyme from other sources (E. coli, Y. pestis, S. typhi, H. influenzae, Homo sapiens, S. cere isiae) is that AZT-MP is not used as substrate by the former, but was reported to be a substrate for the latter enzymes [3, 6, 7] . No activity could be detected with AZT-MP, even in the presence of a concentration of S. pneumoniae TMK that was 100-fold higher than that used with dTMP. Similarly to S. pneumoniae TMK, the enzyme from the Gram-positive human pathogen M. tuberculosis, a bacterium insensitive to AZT, does not use AZT-MP as a . Numbers adjacent to the residues refer to the position of the first and last amino acids of each region. Residues that are thought to be involved in phosphorylation are underlined : those that are conserved with E. coli are singly underlined, and those that are variable are doubly underlined. Lower-case residues indicate non-alignable residues across all species in the multiple sequence alignment.
substrate [7] . The same authors observed that S. typhi TMK phosphorylates AZT-MP at a maximum rate comparable with that observed with TMK coli (2-5-fold reduction in V max ), whereas TMK influenzae is more similar to TMK pestis (100-fold reduction in V max ) [7] .
To gain a further insight into the substrate specificity of the TMK enzymes, we compared the primary protein structures of twelve bacterial and three eukaryotic enzymes ( Figure 6 ). From previous studies of structure and sequence comparisons, it was noted that the variation in maximum phosphorylation rates of AZT-MP between E. coli and eukaryotic TMK enzymes was most likely due to the position of an essential arginine, which is located in the P-loop of eukaryotic TMK enzymes and in the LID region in bacterial TMK enzymes. The rationale explaining the variation observed amongst the bacterial species E. coli\S. typhi and Y. pestis\H. influenzae was a little harder to identify. From structure and sequence analyses, it was hypothesized that the variation in V max of AZT-MP phosphorylation is due to the variability in a few residues within the active site [7] . Further analysis of the primary structures indicates that the main mutation responsible for the variability in bacteria is the leucine lysine substitution (residue 55 in E. coli, Y. pestis, S. typhi, and H. influenzae), since it is the only mutation consistent with the activity data obtained with AZT-MP. This residue is conserved between S. pneumoniae and E. coli ( Figure 6 ). Therefore one would initially expect the V max to be similar. The complete lack of phosphorylation of AZT-MP in S. pneumoniae must therefore be due to some other mutation(s). The only other variability between E. coli and S. pneumoniae around the phosphate-binding site is in the LID region, with the S. pneumoniae LID region having two extra residues. In fact, the arginine residue that is needed to stabilize the transition state is not in the same location within the LID. This difference holds true for the Mycobacterium enzyme, which has an even larger LID region. Without crystalstructure data on S. pneumoniae, we can only speculate that the larger amide group on AZT-MP forces the arginine out of position and therefore phosphoryl transfer cannot be achieved. If this is true, we should expect similar results for Staphylococcus aureus, Bacillus subtilis and Ureaplasma par um ( Figure 6 ).
In conclusion, kinetic parameters have been determined for the forward reaction catalysed by S. pneumoniae TMK. TMK catalyses the phosphoryl transfer via a sequential mechanism. The data presented here support an ordered mechanism. Formation of a binary complex of ATP with S. pneumoniae TMK is a stringent prerequisite for dTMP binding. This implies that ATP binding in fact generates the dTMP-binding site. In this case, one would expect the enzyme to undergo considerable conformation rearrangements. The details of such rearrangements must await a firm structural foundation. Work is currently in progress to solve the crystal structure of the apo form of S. pneumoniae TMK, as well as the forms of the enzyme in complex with substrate nucleotides and substrate analogues. The crystal structures will also help identify the segments lying outside the main nucleotide-binding and catalytic regions, which are responsible for the lack of AZT-MP phosphorylation in S. pneumoniae.
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